August 21, 2025 · Form 4 insider transaction
Sibold William John sold 1,131 shares of Madrigal Pharmaceuticals, Inc. at $401.00 per share, a transaction worth $453.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.00 to $401.01, inclusive.